相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The functions and regulation of Smurfs in cancers
Lin Fu et al.
SEMINARS IN CANCER BIOLOGY (2020)
PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis
Ahlem Essakly et al.
TRANSLATIONAL ONCOLOGY (2020)
Identification of Subtypes of Barrett’s Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data
SriGanesh Jammula et al.
GASTROENTEROLOGY (2020)
The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression
Shih-Chiang Huang et al.
HISTOPATHOLOGY (2020)
ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21
Irene Cosi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Alexander M. Frankell et al.
NATURE GENETICS (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
Ruben S. A. Goedegebuure et al.
FRONTIERS IN IMMUNOLOGY (2019)
Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway
Xiang-Liu Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1
Nikhil Tyagi et al.
MOLECULAR CANCER RESEARCH (2018)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
Eirini Pectasides et al.
CANCER DISCOVERY (2018)
CDKN2A Copy Number Loss Is an Independent Prognostic Factor in HPV-Negative Head and Neck Squamous Cell Carcinoma
William S. Chen et al.
FRONTIERS IN ONCOLOGY (2018)
Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Shumei Kato et al.
CLINICAL CANCER RESEARCH (2018)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells
Youmao Tao et al.
ONCOLOGY REPORTS (2017)
Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma
Swati Shree Padhi et al.
ORAL ONCOLOGY (2017)
Non responders to neoadjuvant chemoradiation for esophageal cancer: why better prediction is necessary
Chantal M. den Bakker et al.
JOURNAL OF THORACIC DISEASE (2017)
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Erica Hlavin Bell et al.
CLINICAL CANCER RESEARCH (2016)
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
John M. Findlay et al.
NATURE COMMUNICATIONS (2016)
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
Ran Zhao et al.
EBIOMEDICINE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Oncotator: Cancer Variant Annotation Tool
Alex H. Ramos et al.
HUMAN MUTATION (2015)
Tracking the Genomic Evolution of Esophageal Adenocarcinoma through Neoadjuvant Chemotherapy
Nirupa Murugaesu et al.
CANCER DISCOVERY (2015)
Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review
Chang-Juan Tao et al.
JOURNAL OF CANCER (2015)
A Multifactorial Histopathologic Score for the Prediction of Prognosis of Resected Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy
Rupert Langer et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Genome-Wide Analysis of Esophageal Adenocarcinoma Yields Specific Copy Number Aberrations that Correlate with Prognosis
Adam Frankel et al.
GENES CHROMOSOMES & CANCER (2014)
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
Vera Oppedijk et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly
Astrid Escudero-Esparza et al.
FASEB JOURNAL (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer
Antonija Kreso et al.
SCIENCE (2013)
Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity
Anbarasi Kothandapani et al.
EXPERIMENTAL CELL RESEARCH (2012)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma
R. Keld et al.
BRITISH JOURNAL OF CANCER (2011)
The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma
Richard Keld et al.
MOLECULAR CANCER (2010)
Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma
Maximilian Moergel et al.
ORAL ONCOLOGY (2010)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
p63 null mutation protects mouse oocytes from radio-induced apoptosis
Gabriel Livera et al.
REPRODUCTION (2008)
E1AF promotes breast cancer cell cycle progression via upregulation of Cyclin D3 transcription
Jianhai Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues
Damian M. Kraus et al.
JOURNAL OF IMMUNOLOGY (2006)
Cranking the immunologic engine with chemotherapy: Using context to drive tumor antigen cross-presentation towards useful antitumor immunity
RG van der Most et al.
CANCER RESEARCH (2006)
CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype
JC Brandes et al.
CARCINOGENESIS (2005)
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks
Y Pommier et al.
ONCOGENE (2004)
P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma
NH Cho et al.
GYNECOLOGIC ONCOLOGY (2003)
分享论文
